

Our product, backed by extensive regenerative medical research, may help. “Her audience of athletes and baby boomers are suffering. “We’re excited to have Chris Evert as a part of our outreach efforts,” said Harrell. Realizing how common dry eye disease is-340 million people worldwide suffer from dry eyes-he decided to study a newer generation of medicine: regenerative medicine. Randall Harrell, M.D., researched dry eye disease (DED) caused by meibomian gland dysfunction (MGD) after watching his mother suffer from Mixed Connective Tissue Disease for years. Vice President of Marketing and Corporate Communications.įounder and CEO C. 1 tennis player made complete sense for Regener-Eyes, as she has a captive audience of athletes and baby boomers that understand the need for lubrication and comfort for the eyes, while practicing a sport,” said Heidi Hart Pukas, Sr. Regener-Eyes provides the ease they need to continue to practice and play the sports they love.

“I appreciate the power of community and the ability to bring an ophthalmic solution that so many people within my audience may find useful and life enhancing.”ĭiscomfort and eye irritation can be common for athletes. “I’m very excited to join the Regener-Eyes team,” said Evert. Evert views her partnership with Regener-Eyes as an opportunity to help athletes of all ages understand the benefits of this ophthalmic solution. Regener-Eyes is an ophthalmic solution that aids in supporting eye lubrication for people experiencing eye discomfort or irritation. (PRESS RELEASE) TAMPA, FL - Chris Evert has joined forces with Regener-Eyes to spread awareness of its first-in-class biologic eye drop.
